MedWatch

Analyst: Demant's guidance reflects improved market conditions

Demant exceeded Sydbank's analyst Søren Løntoft Hansen's performance forecast, when the Danish hearing aid firm laid out its guidance for the 2021 fiscal year Tuesday morning.

Photo: Sydbank/PR

On Tuesday morning hearing aid firm Demant presented its forecast for the new fiscal year in connection with the company's 2020 annual financial report.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Extra data boosts Lundbeck's agitation case

Pharmaceutical firm Lundbeck has presented positive new data at a US conference as it seeks approval for its candidate Rexulti as a treatment for agitation in Alzheimer’s patients.

Further reading

Related articles

Latest news

See all jobs